SCHEMBL15134175

SCHEMBL15134175

CCOc1ccc(C(C)C)c(Cl)c1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
RAB9A P51151 1/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 8/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.35
TSHR P16473 3/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MCOLN3 Q8TDD5 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
KDM4E B2RXH2 2/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
RORC P51449 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15012757 0.82 ALDH1A1 (0.41) MAPTL3MBTL1ALDH1A1HTTLMNA
SCHEMBL12534189 0.81 CA1 (0.41) MAPTRAB9AALDH1A1HTTGAA
SCHEMBL9712162 0.79 MAPT (0.40) MAPTL3MBTL1RAB9AATMALDH1A1
SCHEMBL15134162 0.78 ALDH1A1 (0.39) MAPTL3MBTL1ALDH1A1HTTTSHR
SCHEMBL15134160 0.77 ALDH1A1 (0.36) MAPTL3MBTL1RAB9AATMALDH1A1
SCHEMBL13868786 0.76 MAPT (0.42) MAPTL3MBTL1RAB9AATMALDH1A1
SCHEMBL16159971 0.73 ALDH1A1 (0.44) MAPTL3MBTL1ALDH1A1LMNAGAA
SCHEMBL18052935 0.72 MAPT (0.41) MAPTL3MBTL1RAB9AATMALDH1A1
SCHEMBL19122195 0.72 ALDH1A1 (0.40) MAPTL3MBTL1ATMALDH1A1HTT
SCHEMBL11890402 0.72 GAA (0.52) MAPTL3MBTL1ALDH1A1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130190491-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION GILEAD SCIENCES, INC. (US) 2013-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130190491-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION RTF2, REV1, RTF1 MAPT 3573/4885L3MBTL1 607/4885RAB9A 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.